The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
1847 GOEDEKER INC | *W EXP 06/02/202 | 28252C117 | 1,588 | 6,103,824 | SH | SOLE | 6,103,824 | 0 | 0 | ||
2SEVENTY BIO INC | COMMON STOCK | 901384107 | 1,096 | 83,000 | SH | SOLE | 83,000 | 0 | 0 | ||
908 DEVICES INC | COM | 65443P102 | 2,574 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
ADICET BIO INC | COM | 007002108 | 2,190 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 7,920 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 1,618 | 73,000 | SH | SOLE | 73,000 | 0 | 0 | ||
AKOYA BIOSCIENCES INC | COM | 00974H104 | 3,804 | 296,000 | SH | SOLE | 296,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 536 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
ALTIMMUNE INC | COM NEW | 02155H200 | 1,154 | 98,659 | SH | SOLE | 98,659 | 0 | 0 | ||
AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 3,852 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
ANGIODYNAMICS INC | COM | 03475V101 | 767 | 39,640 | SH | SOLE | 39,640 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 981 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 610 | 200,100 | SH | Call | SOLE | 200,100 | 0 | 0 | |
AULT DISRUPTIVE TECHS CORP | COM | 05150A104 | 1,503 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AULT DISRUPTIVE TECHS CORP | *W EXP 99/99/999 | 05150A112 | 7 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 2,180 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 1,915 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 990 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 6,468 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 1,959 | 212,000 | SH | SOLE | 212,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 158 | 17,400 | SH | Call | SOLE | 17,400 | 0 | 0 | |
CARA THERAPEUTICS INC | COM | 140755109 | 3,225 | 353,200 | SH | SOLE | 353,200 | 0 | 0 | ||
CEA INDUSTRIES INC | *W EXP 02/11/202 | 86887P119 | 60 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | ORDINARY SHARES | G2058L103 | 1,996 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CHAVANT CAPITAL ACQUISITN CO | *W EXP 99/99/999 | G2058L111 | 11 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 3,965 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 10,756 | 615,000 | SH | SOLE | 615,000 | 0 | 0 | ||
CINGULATE INC | *W EXP 12/10/202 | 17248W113 | 85 | 270,000 | SH | SOLE | 270,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | CLASS A ORD SHS | G2263T123 | 827 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
COLISEUM ACQUISITION CORP | *W EXP 08/22/202 | G2263T107 | 3 | 28,333 | SH | SOLE | 28,333 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 2,056 | 116,000 | SH | SOLE | 116,000 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | CL A | 19533H108 | 488 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
COLOMBIER ACQUISITION CORP | *W EXP 99/99/999 | 19533H116 | 2 | 16,666 | SH | SOLE | 16,666 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 5,163 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 3,279 | 44,000 | SH | SOLE | 44,000 | 0 | 0 | ||
DIGITAL BRANDS GROUP INC | COM | 25401N101 | 195 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
DIGITAL HEALTH ACQUISITION C | UNIT 11/02/2026 | 253893200 | 1,515 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
DIRECT DIGITAL HOLDINGS INC | *W EXP 02/15/202 | 25461T113 | 70 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
DOUBLEDOWN INTERACTIVE CO LT | ADS | 25862B109 | 588 | 60,876 | SH | SOLE | 60,876 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 2,772 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 7,396 | 1,162,869 | SH | SOLE | 1,162,869 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 3,960 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 9 | 133,333 | SH | SOLE | 133,333 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,767 | 224,541 | SH | SOLE | 224,541 | 0 | 0 | ||
FAT BRANDS INC | *W EXP 07/16/202 | 30258N121 | 965 | 227,000 | SH | SOLE | 227,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 576 | 371,367 | SH | SOLE | 371,367 | 0 | 0 | ||
GIGINTERNATIONAL1 INC | COM | 37518W106 | 2,010 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
GIGINTERNATIONAL1 INC | *W EXP 04/19/202 | 37518W114 | 4 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 5,178 | 114,000 | SH | SOLE | 114,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 2,716 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 2,176 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
GSR II METEORA ACQUISITN COR | UNIT 02/24/2027 | 36263W204 | 499 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 4,236 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 4,034 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 05/09/202 | 41150T116 | 116 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
HARBOR CUSTOM DEVELOPMENT IN | *W EXP 10/04/202 | 41150T124 | 244 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 2,439 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 100 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
HILLMAN SOLUTIONS CORP | COM | 431636109 | 1,909 | 221,000 | SH | SOLE | 221,000 | 0 | 0 | ||
HOLLEY INC | COM | 43538H103 | 840 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ILLUMINA INC | COM | 452327109 | 1,844 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 199 | 97,467 | SH | SOLE | 97,467 | 0 | 0 | ||
IMMUNOGEN INC | COM | 45253H101 | 1,260 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
INDUSTRIAL HUMAN CAPITAL INC | *W EXP 11/27/202 | 45617P112 | 4 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INDUSTRIAL HUMAN CAPITAL INC | COM | 45617P104 | 1,003 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
INOGEN INC | COM | 45780L104 | 3,772 | 156,000 | SH | SOLE | 156,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 5,285 | 268,000 | SH | SOLE | 268,000 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 4,384 | 24,000 | SH | SOLE | 24,000 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 4,281 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 2,270 | 236,000 | SH | SOLE | 236,000 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 1,976 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 1,645 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 3,157 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 2,431 | 88,000 | SH | SOLE | 88,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 2,695 | 147,000 | SH | SOLE | 147,000 | 0 | 0 | ||
LAKESHORE ACQUISITION I CORP | ORDINARY SHARES | G53521103 | 1,997 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
LAKESHORE ACQUISITION I CORP | *W EXP 07/15/202 | G53521111 | 27 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 5,811 | 88,000 | SH | SOLE | 88,000 | 0 | 0 | ||
LIANBIO | SPONSORED ADS | 53000N108 | 681 | 315,191 | SH | SOLE | 315,191 | 0 | 0 | ||
LIGHTNING EMOTORS INC | *W EXP 05/18/202 | 53228T119 | 255 | 652,173 | SH | SOLE | 652,173 | 0 | 0 | ||
LIVANOVA PLC | SHS | G5509L101 | 3,124 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 1,302 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MURPHY CANYON ACQUISITION CO | UNIT 01/25/2027 | 626642201 | 1,012 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
MUSCLE MAKER INC | COM | 627333107 | 692 | 1,796,961 | SH | SOLE | 1,796,961 | 0 | 0 | ||
MYRIAD GENETICS INC | COM | 62855J104 | 4,016 | 221,000 | SH | SOLE | 221,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 2,145 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 3,901 | 89,000 | SH | SOLE | 89,000 | 0 | 0 | ||
NEXGEL INC | *W EXP 12/01/202 | 65344E115 | 63 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | *W EXP 09/25/202 | H57830111 | 24 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | RIGHT 12/26/2025 | G6580S106 | 20 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
NOCTURNE ACQUISITION CORP | ORDINARY SHARES | G6580S114 | 5,095 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 2,794 | 695,000 | SH | SOLE | 695,000 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 985 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | COM CL A | 671005106 | 984 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
OPY ACQUISITION CORP I | *W EXP 09/22/202 | 671005114 | 9 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 1,544 | 103,880 | SH | SOLE | 103,880 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | 794 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | *W EXP 10/01/202 | G70021111 | 76 | 367,500 | SH | SOLE | 367,500 | 0 | 0 | ||
PEPPERLIME HEALTH ACQUSTN CO | CLASS A ORD SHS | G70021103 | 7,251 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 3,204 | 98,000 | SH | SOLE | 98,000 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 1,101 | 39,000 | SH | SOLE | 39,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 2,888 | 365,100 | SH | Call | SOLE | 365,100 | 0 | 0 | |
QUIDELORTHO CORP | COM | 219798105 | 4,859 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
RELATIVITY ACQUISITION CORP | UNIT 02/10/2027 | 75944B205 | 1,025 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 532 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
RENOVACOR INC | *W EXP 99/99/999 | 75989E114 | 51 | 731,561 | SH | SOLE | 731,561 | 0 | 0 | ||
RENOVACOR INC | COM | 75989E106 | 788 | 388,845 | SH | SOLE | 388,845 | 0 | 0 | ||
REPRO MED SYS INC | COM | 759910102 | 2,519 | 995,500 | SH | SOLE | 995,500 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 1,328 | 411,000 | SH | SOLE | 411,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 485 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | CL A | G7823W102 | 2,225 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
SARISSA CAPITAL ACQUISITN CO | *W EXP 10/23/202 | G7823W110 | 6 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SHOCKWAVE MED INC | COM | 82489T104 | 2,294 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
SONENDO INC | COM | 835431107 | 65 | 37,572 | SH | SOLE | 37,572 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 5,320 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 634 | 48,000 | SH | SOLE | 48,000 | 0 | 0 | ||
SURGEPAYS INC | *W EXP 10/22/202 | 86882L113 | 300 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 16 | 82,233 | SH | SOLE | 82,233 | 0 | 0 | ||
TAILWIND ACQUISITION CORP | COM CL A | 87403Q102 | 1,278 | 128,414 | SH | SOLE | 128,414 | 0 | 0 | ||
TC BIOPHARM HOLDINGS PLC | *W EXP 02/08/202 | 87807D111 | 223 | 941,176 | SH | SOLE | 941,176 | 0 | 0 | ||
TG VENTURE ACQUISITION CORP | UNIT 08/15/2028 | 87251T208 | 2,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 3,608 | 1,284,000 | SH | SOLE | 1,284,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 8 | 84,666 | SH | SOLE | 84,666 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 2,518 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 3,480 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
WESTERN ACQSTN VENTURES CORP | UNIT 09/01/2026 | 95758L206 | 1,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
XTANT MED HLDGS INC | COM NEW | 98420P308 | 3,245 | 6,246,291 | SH | SOLE | 6,246,291 | 0 | 0 |